GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Camurus CAMX.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

741.00

+1.37%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 2.27bn

FY2016FY2025

Net income

SEK 735.6m

FY2016FY2025

Free cash flow

SEK 730.8m

FY2016FY2025

Shareholders' equity

SEK 4.24bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 2.27bnSEK 1.87bnSEK 1.72bnSEK 956.3mSEK 600.6mSEK 336.0mSEK 105.6mSEK 49.3mSEK 54.3mSEK 113.7m
Gross profitSEK 2.11bnSEK 1.74bnSEK 1.59bnSEK 853.1mSEK 515.2mSEK 300.7mSEK 82.3mSEK 42.5mSEK 53.0mSEK 111.6m
Research and developmentSEK 516.9mSEK 683.6mSEK 637.7mSEK 473.8mSEK 388.7mSEK 238.7mSEK 249.2mSEK 207.7mSEK 222.9mSEK 172.1m
Operating incomeSEK 884.2mSEK 469.2mSEK 532.4mSEK 72.0m−SEK 112.4m−SEK 205.2m−SEK 360.0m−SEK 287.2m−SEK 243.5m−SEK 102.5m
Net incomeSEK 735.6mSEK 428.4mSEK 431.4mSEK 55.6m−SEK 90.4m−SEK 167.3m−SEK 289.9m−SEK 234.7m−SEK 190.6m−SEK 81.0m
Diluted earnings per share12.207.157.770.97-1.59-3.01-5.41-5.02-4.55-1.97

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 4.74bnSEK 3.76bnSEK 1.91bnSEK 1.31bnSEK 1.08bnSEK 1.04bnSEK 772.0mSEK 364.7mSEK 475.9mSEK 639.8m
Cash and short-term investmentsSEK 3.73bnSEK 2.85bnSEK 1.19bnSEK 565.5mSEK 411.6mSEK 461.8mSEK 358.7mSEK 134.4mSEK 314.5mSEK 508.6m
Total liabilitiesSEK 504.6mSEK 467.3mSEK 414.8mSEK 301.8mSEK 233.0mSEK 196.7mSEK 140.4mSEK 112.4mSEK 90.9mSEK 75.4m
DebtSEK 106.0mSEK 17.0mSEK 24.5mSEK 26.2mSEK 25.7mSEK 25.5mSEK 27.3m———
Shareholders' equitySEK 4.24bnSEK 3.29bnSEK 1.49bnSEK 999.0mSEK 848.9mSEK 847.4mSEK 631.6mSEK 252.3mSEK 385.0mSEK 564.4m
Shares outstanding60m60m56m58m57m56m54m47m42m41m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 869.3mSEK 388.0mSEK 606.9mSEK 101.2m−SEK 143.4m−SEK 238.8m−SEK 404.4m−SEK 274.1m−SEK 203.1m−SEK 207.8m
Capital spending−SEK 138.5m−SEK 29.4m−SEK 10.1m−SEK 1.9m−SEK 4.9m−SEK 3.3m−SEK 25.9m−SEK 4.8m−SEK 2.1m−SEK 4.6m
Free cash flowSEK 730.8mSEK 358.6mSEK 596.8mSEK 99.3m−SEK 148.4m−SEK 242.2m−SEK 430.3m−SEK 278.8m−SEK 205.2m−SEK 212.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 702.1mSEK 533.1mSEK 464.5mSEK 567.1mSEK 675.5mSEK 558.3mSEK 553.1mSEK 479.6m
Gross profitSEK 657.9mSEK 489.1mSEK 428.1mSEK 521.3mSEK 634.4mSEK 519.0mSEK 519.8mSEK 446.1m
Operating incomeSEK 292.5mSEK 180.8mSEK 112.8mSEK 237.3mSEK 292.0mSEK 238.9mSEK 166.1mSEK 141.8m
Net incomeSEK 240.8mSEK 143.8mSEK 100.9mSEK 192.6mSEK 244.8mSEK 197.3mSEK 147.0mSEK 129.3m
Diluted earnings per share4.052.421.673.194.063.272.452.16
Cash from operationsSEK 234.0mSEK 162.0mSEK 255.0mSEK 160.0mSEK 375.0mSEK 77.0mSEK 103.0mSEK 149.0m
Capital spending−SEK 41.0m−SEK 39.0m−SEK 45.0m−SEK 30.0m−SEK 27.0m−SEK 34.0m−SEK 19.0m−SEK 5.0m
Free cash flowSEK 193.0mSEK 123.0mSEK 210.0mSEK 130.0mSEK 348.0mSEK 43.0mSEK 84.0mSEK 144.0m
Total assetsSEK 5.31bnSEK 4.96bnSEK 4.74bnSEK 4.63bnSEK 4.42bnSEK 3.97bnSEK 3.76bnSEK 3.57bn
Cash and short-term investmentsSEK 4.07bnSEK 3.88bnSEK 3.73bnSEK 3.51bnSEK 3.35bnSEK 2.88bnSEK 2.85bnSEK 2.75bn
DebtSEK 21.6mSEK 21.4mSEK 106.0mSEK 106.3mSEK 103.8mSEK 106.6mSEK 17.0mSEK 9.9m
Shareholders' equitySEK 4.68bnSEK 4.42bnSEK 4.24bnSEK 4.12bnSEK 3.87bnSEK 3.49bnSEK 3.29bnSEK 3.11bn

Financial ratios

Data as of 23 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin93.1%93.1%92.9%89.2%85.8%89.5%
Operating margin39.0%25.1%31.0%7.5%-18.7%-61.1%
Net margin32.5%22.9%25.1%5.8%-15.1%-49.8%
Return on equity17.4%13.0%28.9%5.6%-10.7%-19.7%
Return on assets15.5%11.4%22.6%4.3%-8.4%-16.0%
Free cash flow yield2.7%1.1%1.8%0.3%-0.4%-0.7%
Revenue growth21.3%8.8%79.5%59.2%78.7%218.2%
Earnings growth71.7%-0.7%676.6%-161.4%-45.9%-42.3%
Current ratio12.09x8.09x4.41x3.36x3.19x3.79x
Debt to equity0.00x0.00x0.01x0.01x0.01x0.07x
Equity ratio89.4%87.6%78.3%76.5%78.5%81.2%
Interest coverage153.56x432.81x417.53x47.15x-82.31x-133.18x
R&D as a share of sales22.8%36.6%37.1%49.5%64.7%71.0%
Buybacks as a share of market value-0.6%-7.9%3.5%-1.5%-1.9%-3.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue33.3%46.5%30.8%
Operating income130.8%——
Net income136.6%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin93.1%92.5%91.8%91.9%
Operating margin32.7%28.8%21.2%5.4%
Net margin28.2%24.3%18.0%5.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings50.579.169.3261.7-94.6-62.0-15.6-12.2-27.4-54.1
Price to sales16.418.117.415.214.230.942.958.096.038.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.